This announcement is a separate document:
精優藥業：主要交易領航醫藥及生物科技有限公司所發行可換股債券之條款及條件之第二次修訂及股東特別大會通告
EXTRAWELL PHAR: MAJOR TRANSACTION CONCERNING THE SECOND AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS ISSUED BY INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED AND NOTICE OF SPECIAL GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.